| IDEXX LABS INC. DL-,10 |
| USA |
| Gesundheit |
| US45168D1046 / 888210 |
| IX1 (Frankfurt) / IDXX (NASDAQ) |
| FRA:IX1, ETR:IX1, IX1:GR, NASDAQ:IDXX |
| https://www.idexx.com/ |
|
IDEXX Laboratories, Inc. is a global leader in the..
>Volltext.. |
| 45598.43 Mio. EUR |
| 46377.25 Mio. EUR |
| 3516.67 Mio. EUR |
| 1221.83 Mio. EUR |
| 866.99 Mio. EUR |
| 10.73 EUR |
| 939.17 Mio. EUR |
| 175.66 Mio. EUR |
| 918.17 Mio. EUR |
| 0.17 |
| 2.85% |
| 12.54% |
| - |
| - |
| - |
| - |
| IDEXX |
| 02.02.26 |